Selection of Resistance Mutations in Children Receiving Prophylaxis With Lamivudine or Nevirapine for the Prevention of Postnatal Transmission of HIV
- 1 May 2006
- journal article
- letter
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 42 (1) , 131-133
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Intrapartum Exposure to Nevirapine and Subsequent Maternal Responses to Nevirapine-Based Antiretroviral TherapyNew England Journal of Medicine, 2004
- Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)AIDS, 2001
- Lamivudine-Zidovudine Combination for Prevention of Maternal-Infant Transmission of HIV-1JAMA, 2001
- Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotypeAIDS, 1999